1 EVERTRUST PLAZA, JERSEY CITY, NJ
Binding MOU for Amendment to Exclusive License Agreement with GSK
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Other Events
Investor Presentation
Shareholder votes
Annual Report to Security Holders
Reports Full Year 2023 Financial Results and Provides Corporate Update
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Free Writing Prospectus